OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
Meg Rivers is the former senior editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.
Experts reveal how to identify the “right” biochemical, the process of sourcing biochemicals, sourcing challenges, and what industry professionals should know about the space.
Research into oncolytic viruses potentiated by stem cells shows promise for treating cancer.
While a variety of innovations have already impacted the drug delivery landscape, improving sustainability and having the ability to make smaller volumes of drug products still require work.
Experts divulge where the industry is outsourcing most frequently, when companies should outsource more, and when performing tasks in-house might be best.
Avoiding roadblocks through strategic planning early on can help facilitate IND application filings.
Industry experts share their top outsourcing tips from both the perspective of companies offering outsourcing services as well as for companies looking to outsource.
New technologies are treatments are emerging to tackle COVID-19 and its assortment of new variants.
CGTs offer hope for the future of treatments, but the costly manufacturing, slow turnaround time, and need for supplies hinder progress.
Build into the chemistry, manufacturing, and control strategy the ability to pivot and be flexible should the course change.
Although mRNA and viral vector vaccines have been top of mind for COVID-19 treatments, other technologies and treatments are emerging—along with new variants.